DK296789A - Chromanderivater - Google Patents

Chromanderivater Download PDF

Info

Publication number
DK296789A
DK296789A DK296789A DK296789A DK296789A DK 296789 A DK296789 A DK 296789A DK 296789 A DK296789 A DK 296789A DK 296789 A DK296789 A DK 296789A DK 296789 A DK296789 A DK 296789A
Authority
DK
Denmark
Prior art keywords
chroman
Prior art date
Application number
DK296789A
Other languages
English (en)
Other versions
DK296789D0 (da
Inventor
Guenther Haeusler
Rolf Gericke
Hanns Wurziger
Manfred Baumbarth
Ingeborg Lues
Rolf Bergmann
Jacques De Peyer
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE3820506A external-priority patent/DE3820506A1/de
Priority claimed from DE3835011A external-priority patent/DE3835011A1/de
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of DK296789D0 publication Critical patent/DK296789D0/da
Publication of DK296789A publication Critical patent/DK296789A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Cosmetics (AREA)
DK296789A 1988-06-16 1989-06-15 Chromanderivater DK296789A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3820506A DE3820506A1 (de) 1988-06-16 1988-06-16 -n-heterocyclisch substituierte chromanderivate und ihre verwendung als arzneimittel
DE3835011A DE3835011A1 (de) 1988-10-14 1988-10-14 Chromanderivate

Publications (2)

Publication Number Publication Date
DK296789D0 DK296789D0 (da) 1989-06-15
DK296789A true DK296789A (da) 1989-12-17

Family

ID=25869185

Family Applications (1)

Application Number Title Priority Date Filing Date
DK296789A DK296789A (da) 1988-06-16 1989-06-15 Chromanderivater

Country Status (11)

Country Link
EP (1) EP0346724A1 (da)
JP (1) JPH0240375A (da)
KR (1) KR910000711A (da)
AU (1) AU626549B2 (da)
DK (1) DK296789A (da)
FI (1) FI92824C (da)
HU (1) HUT56096A (da)
IL (1) IL90613A0 (da)
NO (1) NO174391C (da)
NZ (1) NZ229540A (da)
PT (1) PT90864B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3835011A1 (de) * 1988-10-14 1990-04-19 Merck Patent Gmbh Chromanderivate
FR2621587B1 (fr) * 1987-10-12 1990-02-09 Sanofi Sa Derives du dimethyl-2,2 chromene, procede pour leur preparation et composition pharmaceutiques les contenant
AU628331B2 (en) * 1988-05-06 1992-09-17 Merck Patent Gesellschaft Mit Beschrankter Haftung Chroman derivatives
DE3918041A1 (de) * 1989-06-02 1990-12-06 Merck Patent Gmbh Chromanderivate
GB8924376D0 (en) * 1989-10-30 1989-12-20 Beecham Group Plc Novel compounds
EP0430621A3 (en) * 1989-11-29 1992-03-04 Beecham Group P.L.C. Process for the preparation of chiral 3,4-epoxy benzopyrans
JP2575226B2 (ja) * 1990-05-11 1997-01-22 吉富製薬株式会社 光学活性な3,4−ジヒドロ−3,4−エポキシ−2h−1ベンゾピラン化合物の製造法およびその合成中間体
TW257762B (da) * 1991-06-14 1995-09-21 Nippon Chemicals Pharmaceutical Co Ltd
CA2122494A1 (en) * 1992-11-25 1994-06-09 Paul W. Manley 2,2-dialkyl- and 2,2-dialkyl-3,4-dihydro-3-hydroxy-2h-1- benzopyrans
WO1994012493A1 (en) * 1992-11-25 1994-06-09 Sandoz, Ltd. 2,2-dialkyl- and 2,2-dialkyl-3,4-dihydro-3-hydroxy-2h-1-benzopyr ans, their use as pharmaceuticals
IL108841A0 (en) * 1993-03-10 1994-06-24 Pfizer Res & Dev Benzopyrans
GB9316111D0 (en) * 1993-08-04 1993-09-22 Pfizer Ltd Benzopyrans
US5574049A (en) * 1994-07-22 1996-11-12 Sandoz Ltd. 2,2-dialkyl- and 2,2-dialkyl-3,4-dihydro-3-hydroxy-2H-1-benzopyrans
JP2007000772A (ja) * 2005-06-23 2007-01-11 Casio Electronics Co Ltd 二重マイクロカプセル、その製造方法及びマイクロカプセルの表面処理方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2107706A (en) * 1981-09-25 1983-05-05 Beecham Group Plc Benzopyrans
DE3364734D1 (en) * 1982-10-19 1986-08-28 Beecham Group Plc Novel chromans and chromenes
PT84806B (pt) * 1986-05-03 1989-12-29 Beecham Group Plc Processo para a preparacao de benzopiranos
DE3726261A1 (de) * 1986-12-23 1988-07-07 Merck Patent Gmbh Chromanderivate
CH674984A5 (da) * 1987-05-16 1990-08-15 Sandoz Ag
FR2621587B1 (fr) * 1987-10-12 1990-02-09 Sanofi Sa Derives du dimethyl-2,2 chromene, procede pour leur preparation et composition pharmaceutiques les contenant
AU628331B2 (en) * 1988-05-06 1992-09-17 Merck Patent Gesellschaft Mit Beschrankter Haftung Chroman derivatives

Also Published As

Publication number Publication date
NO174391C (no) 1994-04-27
PT90864B (pt) 1994-11-30
FI92824C (fi) 1995-01-10
NO892494L (no) 1989-12-18
FI92824B (fi) 1994-09-30
NZ229540A (en) 1991-03-26
NO174391B (no) 1994-01-17
KR910000711A (ko) 1991-01-30
FI892948A0 (fi) 1989-06-15
AU626549B2 (en) 1992-08-06
JPH0240375A (ja) 1990-02-09
NO892494D0 (no) 1989-06-15
PT90864A (pt) 1989-12-29
EP0346724A1 (de) 1989-12-20
AU3644089A (en) 1989-12-21
FI892948A (fi) 1989-12-17
DK296789D0 (da) 1989-06-15
HUT56096A (en) 1991-07-29
IL90613A0 (en) 1990-01-18

Similar Documents

Publication Publication Date Title
ATA901789A (de) Somatostatinpeptid
BR8806093A (pt) Trepano
DK370988A (da) Benzopyranderivater
DK223289A (da) Chromanderivater
ATA900689A (de) Calcitoninpeptide
ATA172889A (de) Furanderivate
DK296789A (da) Chromanderivater
DK0415065T3 (da) Chromanderivater
DK0400430T3 (da) Chromanderivater
DK0410208T3 (da) Chromanderivater
DK511089D0 (da) Chromanderivater
DK0406656T3 (da) Chromanderivater
DE68926597D1 (de) Mikrorechner
BR8902098A (pt) Eletrolisador
DK622089A (da) Benzopyranderivater
BR8906898A (pt) Jamela
DE68926367D1 (de) Hydroxymethylcyclobutylpurine
DK413289A (da) Benzopyranderivater
DD277186A3 (de) Waelzlagerseparator
BR6800741U (pt) Morsa independente
FI88603C (fi) Noedbroms
BR6801307U (pt) Boneco-luva
BR6800871U (pt) Giro-arte
BR8801701A (pt) Anti-ivh
BR8806404A (pt) Multiregua

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment